Authors:
Shiga, H
Rasmussen, AA
Johnston, PG
Langmacher, M
Baylor, A
Lee, M
Cullen, KJ
Citation: H. Shiga et al., Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer, HEAD NECK, 22(6), 2000, pp. 599-608
Authors:
Yang, ZJ
Faustino, PJ
Andrews, PA
Monastra, R
Rasmussen, AA
Ellison, CD
Cullen, KJ
Citation: Zj. Yang et al., Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines, CANC CHEMOT, 46(4), 2000, pp. 255-262
Authors:
Shiga, H
Heath, EI
Rasmussen, AA
Trock, B
Johnston, PG
Forastiere, AA
Langmacher, M
Baylor, A
Lee, M
Cullen, KJ
Citation: H. Shiga et al., Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer, CLIN CANC R, 5(12), 1999, pp. 4097-4104
Citation: Kj. Cullen et al., Interactions between stroma and epithelium in breast cancer - Implicationsfor tumor genesis, growth, and progression, CONT ENDOC, 11, 1999, pp. 155-168